ILT101

DRUG3 trials

Sponsors

Assistance Publique - Hôpitaux de Paris

Conditions

Bipolar DepressionHealthy VolunteersType 1 Diabetes

Phase 1

Low-dose IL-2 to the Kinetics of Regulatory T-cell in Healthy Volunteers

CompletedNCT03837093

Assistance Publique - Hôpitaux de ParisHealthy Volunteers

Start: 2019-06-06End: 2021-11-06Updated: 2021-12-30

Phase 2

Low Dose IL-2 Therapy in Patients With a Depressive Episode in the Course of a Bipolar Disorder

CompletedNCT04133233

Assistance Publique - Hôpitaux de ParisBipolar Depression

Start: 2020-06-15End: 2022-05-21Updated: 2026-04-06

Ciclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 Diabetes

RecruitingNCT05153070

Assistance Publique - Hôpitaux de ParisType 1 Diabetes

Start: 2022-09-21End: 2028-04-21Target: 24Updated: 2025-06-27

Related Papers

Low-dose interleukin-2 in patients with bipolar depression: A phase 2 randomised double-blind placebo-controlled trial.

2024-09-046 citations